KYLE ANDERSON: Open Payments
NPI 1508459231 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 19 payments from 14 companies in 2025. Trend: 2023 $762 · 2024 $672 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| Novo Nordisk Inc | 1 | $118 |
| PFIZER INC. | 2 | $36 |
| Amgen Inc. | 1 | $28 |
| SANOFI PASTEUR INC. | 1 | $27 |
| Lucid Diagnostics Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
Products named: AIRSUPRA, Kerendia, TZIELD, Ozempic, NURTEC ODT, KRYSTEXXA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, JARDIANCE.
Industry payments across NV — which companies pay providers there.
